Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides

Oligonucleotide-functionalized gold nanoparticles for synchronous telomerase inhibition, radiosensitization, and delivery of theranostic radionuclides

<p>Telomerase represents an attractive target in oncology as it is expressed in cancer but not in normal tissues. The oligonucleotide inhibitors of telomerase represent a promising anticancer strategy, although poor cellular uptake can restrict their efficacy. In this study, gold nanoparticles...

Полное описание

Библиографические подробности
Главные авторы:	Bavelaar, BM, Song, L, Jackson, MR, Able, S, Tietz, O, Skaripa-Koukelli, I, Waghorn, PA, Gill, MR, Carlisle, RC, Tarsounas, M, Vallis, KA
Формат:	Journal article
Язык:	English
Опубликовано:	American Chemical Society 2021

Схожие документы

Radiolabeled oligonucleotides targeting the RNA subunit of telomerase inhibit telomerase and induce DNA damage in telomerase-positive cancer cells
по: Jackson, MR, и др.
Опубликовано: (2019)

Subcellular targeting of theranostic radionuclides
по: Bavelaar, B, и др.
Опубликовано: (2018)

Subcellular Targeting of Theranostic Radionuclides
по: Bas M. Bavelaar, и др.
Опубликовано: (2018-09-01)

111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
по: Gill, M, и др.
Опубликовано: (2018)

Indium-111 labelling of liposomal HEGF for radionuclide delivery via ultrasound-induced cavitation
по: Owen, J, и др.
Опубликовано: (2019)

An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells
по: Gill, MR, и др.
Опубликовано: (2020)

Targeting telomerase with radiolabeled inhibitors.
по: Waghorn, P, и др.
Опубликовано: (2016)

Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy
по: Thomas, E, и др.
Опубликовано: (2019)

Towards the synthesis and delivery of a halogenated MCT1 substrate
по: Skaripa-Koukelli, Eirini
Опубликовано: (2019)

Telomerase-targeting radiopharmaceuticals for the selective treatment of cancer
по: Bavelaar, B
Опубликовано: (2018)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
по: Skaripa-Koukelli, I, и др.
Опубликовано: (2021)

Transition metal compounds as cancer radiosensitizers
по: Gill, M, и др.
Опубликовано: (2018)

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation
по: Irini Skaripa-Koukelli, и др.
Опубликовано: (2021-10-01)

Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma
по: Satarupa Sengupta, и др.
Опубликовано: (2023-01-01)

Targeting micrometastases: The effect of heterogeneous radionuclide distribution on tumor control probability
по: Falzone, N, и др.
Опубликовано: (2018)

Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
по: Lee, B, и др.
Опубликовано: (2019)

Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma
по: Pengcheng Hu, и др.
Опубликовано: (2019-11-01)

Population pharmacokinetics of imetelstat, a first‐in‐class oligonucleotide telomerase inhibitor
по: Mario González‐Sales, и др.
Опубликовано: (2024-07-01)

Targeted radionuclide therapy in combined-modality regimens
по: Gill, M, и др.
Опубликовано: (2017)

A three-in-one-bullet for oesophageal cancer: replication fork collapse, spindle attachment failure and enhanced radiosensitivity generated by a ruthenium(II) metallo-intercalator
по: Gill, MR, и др.
Опубликовано: (2017)

Exposing the Rad to Radionuclide: Why Early Education in Theranostics Is Important to Radiologists
по: Andy Ho, и др.
Опубликовано: (2025-02-01)

Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc
по: C. Shaun Loveless, и др.
Опубликовано: (2019-05-01)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
по: Rou Li, и др.
Опубликовано: (2021-01-01)

Emulsion Technology in Nuclear Medicine: Targeted Radionuclide Therapies, Radiosensitizers, and Imaging Agents
по: Winuprasith T, и др.
Опубликовано: (2023-08-01)

Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
по: Kazmi, F, и др.
Опубликовано: (2020)

The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker
по: Holis Abdul Holik, и др.
Опубликовано: (2022-05-01)

A Theoretical and Experimental study of the Theranostic Radionuclide Scandium-47 in Karaj Cyclotron
по: A. Jafari, и др.
Опубликовано: (2021-06-01)

Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells
по: Tietz, O, и др.
Опубликовано: (2022)

Copper radionuclides for theranostic applications: towards standardisation of their nuclear data. A mini-review
по: Mazhar Hussain, и др.
Опубликовано: (2023-09-01)

Low Proarrhythmic Risk of Imetelstat, a Novel Oligonucleotide Telomerase Inhibitor: A Translational Analysis
по: Ashley L. Lennox, и др.
Опубликовано: (2025-02-01)

Targeting the nucleus: an overview of Auger-electron radionuclide therapy.
по: Cornelissen, B, и др.
Опубликовано: (2010)

Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes.
по: Cornelissen, B
Опубликовано: (2014)

Radionuclide targeted therapy, theranostics, and precision medicine in the era of hybrid imaging: an important pillar in cancer care
по: Suppiah, Subapriya, и др.
Опубликовано: (2022)

Advances in prostate-specific membrane antigen-targeted theranostics: from radionuclides to near-infrared fluorescence technology
по: Zhongji Jiang, и др.
Опубликовано: (2025-01-01)

The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
по: Frank Rösch, и др.
Опубликовано: (2017-06-01)

Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
по: Cornelissen, B, и др.
Опубликовано: (2013)

Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
по: Song, L, и др.
Опубликовано: (2017)

Modular and automated synthesis of oligonucleotide-small molecule conjugates for cathepsin B mediated traceless release of payloads † ‡
по: Jin, C, и др.
Опубликовано: (2024)

Cytotoxic effect of combining two antisense oligonucleotides against telomerase rna component (hTR and mRNA of centromere protein B (CENP-B) in hepatocellular carcinoma cells
по: AHMED M. EL-DESOKY, и др.
Опубликовано: (2022-07-01)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
по: Druce, MR, и др.
Опубликовано: (2010)